{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":759,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":759,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"a8073ea30bc6","filters":{"venue":"Molecular Cancer Therapeutics"}},"results":[{"id":"W2154040159","doi":"10.1158/1535-7163.mct-08-0021","title":"Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":636,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Lethbridge","funders":"Oak Ridge Institute for Science and Education","keywords":"microRNA; Cancer research; Cancer cell; Doxorubicin; Breast cancer chemotherapy; Cancer; Transfection; Biology; Epigenetics; Breast cancer; MCF-7; Drug resistance; Gene silencing; Multiple drug resistance; Cell culture; Gene; Chemotherapy; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0127625030576074,"gpt":0.251522607907698,"spread":0.2387601048500906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001300362,0.0002273809,0.0002592267,0.00007292305,0.00004979413,0.000005413262,0.0004421392,0.0001129017,0.00003222573],"category_scores_gemma":[0.000002914645,0.0001966225,0.000164365,0.000393067,0.0001845584,0.000004065671,0.0001175062,0.0001000678,0.000001174725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001215975,"about_ca_system_score_gemma":0.0003089249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002987227,"about_ca_topic_score_gemma":0.000671403,"domain_scores_codex":[0.9985027,0.0001139881,0.0004240088,0.0003663647,0.0003012051,0.0002916828],"domain_scores_gemma":[0.9988173,0.000007715645,0.0002401255,0.0006850901,0.0001884323,0.0000612994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002278254,0.0001285753,0.007594722,0.00009273171,0.0001457965,0.000001671551,0.0004284585,0.001549562,0.9888824,0.00001924453,0.0002769557,0.0006520728],"study_design_scores_gemma":[0.0007344747,0.00002371277,0.02853227,0.0001468149,0.00005488636,0.000002462006,0.00004079712,0.00002769167,0.9640594,0.0000392812,0.006134213,0.0002040212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893808,0.008169075,0.0003672591,0.001147706,0.0001625521,0.0005451008,0.0001541827,0.000005640661,0.00006769203],"genre_scores_gemma":[0.9962324,0.0009512859,0.000320874,0.001950221,0.00005162844,0.00007387828,0.000008983857,0.00004960885,0.0003611382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02482301,"threshold_uncertainty_score":0.8018032,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138590199","doi":"10.1158/1535-7163.mct-07-0482","title":"Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":435,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Glycolysis; Chemistry; Intracellular; NAD+ kinase; Flux (metallurgy); Biochemistry; Cell culture; Enzyme; Cell growth; Transfection; Cancer cell; Growth inhibition; Kinase; Molecular biology; Biology; Cancer; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01970252644269791,"gpt":0.2464475747441689,"spread":0.226745048301471,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008876949,0.0002901203,0.000318791,0.00006803081,0.0001181753,0.00001834979,0.0001552773,0.0001557849,0.00002781571],"category_scores_gemma":[0.00002464055,0.0003000599,0.0001497026,0.0001806089,0.0003012755,0.000009645661,0.0001199209,0.0001451121,0.00000174781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002775538,"about_ca_system_score_gemma":0.0002499361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000252716,"about_ca_topic_score_gemma":0.00008161881,"domain_scores_codex":[0.9986218,0.00008589008,0.0002437812,0.0004747541,0.0002248197,0.000348945],"domain_scores_gemma":[0.9990821,0.00001019656,0.0001638901,0.0004189223,0.000204461,0.0001204452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002642631,0.0001190982,0.0006945079,0.00007942668,0.0001576506,0.00001871337,0.000116546,0.00002083351,0.9955891,0.00009673805,0.0002666812,0.002576482],"study_design_scores_gemma":[0.001231883,0.0002219068,0.002680138,0.00003037204,0.0001355238,0.00006143812,0.00002304738,0.000043759,0.9787447,0.00009625778,0.01639892,0.000332059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9778957,0.01876942,0.002080436,0.0001413418,0.0003938787,0.0003102128,0.00007909976,0.00002136164,0.0003085493],"genre_scores_gemma":[0.9932715,0.004722629,0.0003433031,0.0009623677,0.0002877077,0.00007187724,0.00004334299,0.00006047352,0.0002367736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01684436,"threshold_uncertainty_score":0.9999452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2299417213","doi":"10.1158/1535-7163.mct-15-0843","title":"An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies","year":2016,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University College of the North","funders":"","keywords":"Cancer; In vivo; Combination therapy; Cancer cell; Pharmacology; Medicine; Computational biology; Cancer therapy; Drug; Cancer research; Cancer treatment; Biology; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03619010624958395,"gpt":0.3574481275927425,"spread":0.3212580213431586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001556712,0.0001726893,0.0001392601,0.00006675508,0.00007781714,0.00006529698,0.0002848188,0.0001698555,0.00004162183],"category_scores_gemma":[0.00001111444,0.000140876,0.00006543916,0.0001227193,0.00008681051,0.00001650374,0.00005376325,0.00006090048,0.00001710071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008091458,"about_ca_system_score_gemma":0.0002150372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006616182,"about_ca_topic_score_gemma":0.0001306849,"domain_scores_codex":[0.9988919,0.00009797918,0.000208081,0.00036074,0.0001938397,0.0002474025],"domain_scores_gemma":[0.9991863,0.000008816042,0.00008853555,0.0004147899,0.0001814747,0.0001200979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009390715,0.0001374547,0.0002018017,0.000003579157,0.00007125629,0.000003223186,0.00004002374,0.00006266639,0.9744848,0.001530322,0.0002278475,0.02314314],"study_design_scores_gemma":[0.001262494,0.0006588066,0.001752551,0.00002024566,0.0000272952,0.00000521488,0.00008044876,0.00005197941,0.8664481,0.0003502244,0.1290907,0.0002519582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7615134,0.0003977157,0.23421,0.002436335,0.000271722,0.0003532871,0.00006239147,0.00003626699,0.000718889],"genre_scores_gemma":[0.9941135,0.0001085029,0.001369945,0.003888737,0.0001347971,0.00006854275,0.00008963313,0.0000365254,0.0001898132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2328401,"threshold_uncertainty_score":0.5744758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155784435","doi":"10.1158/1535-7163.mct-06-0596","title":"Radiation-induced cell signaling: inside-out and outside-in","year":2007,"lang":"en","type":"review","venue":"Molecular Cancer Therapeutics","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Cell biology; Paracrine signalling; Signal transduction; Autocrine signalling; Biology; Cell signaling; Kinase; Protein kinase B; Intracellular; Receptor; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.07123259998810326,"gpt":0.3835587938491868,"spread":0.3123261938610836,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004123628,0.0005384089,0.001490515,0.0004982231,0.0000433374,0.00004077927,0.0001565021,0.0006537622,0.00003627879],"category_scores_gemma":[0.00003103992,0.0004911497,0.0004052756,0.000427125,0.00004741932,0.00004708827,0.00003722269,0.0008010858,0.00003079397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000438103,"about_ca_system_score_gemma":0.0007329495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004828013,"about_ca_topic_score_gemma":0.00002580768,"domain_scores_codex":[0.9976617,0.0002062245,0.0007150014,0.0005538302,0.0004376188,0.0004256617],"domain_scores_gemma":[0.9985963,0.0002250385,0.0003743576,0.0005215856,0.00009625791,0.0001865324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001761552,0.0000725512,0.0001665104,0.006422292,0.000381215,0.0002471101,0.0002652204,0.000007709762,0.0009125379,0.00003118148,0.00003254025,0.9914435],"study_design_scores_gemma":[0.00131656,0.0001974399,0.00005091725,0.003941604,0.002154911,0.00003707354,0.00001699624,0.00003088189,0.002461337,0.00003348601,0.9892251,0.0005336911],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007705213,0.9959733,0.0002635153,0.0001910503,0.0003692598,0.001520556,0.00001723553,0.00006164886,0.0008329456],"genre_scores_gemma":[0.004269201,0.992408,0.0003263862,0.002155415,0.0002519682,0.0001260629,0.00007536196,0.0001695099,0.000218044],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9909098,"threshold_uncertainty_score":0.999754,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136923586","doi":"10.1158/1535-7163.mct-06-0118","title":"Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":326,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Celator Pharmaceuticals (Canada)","funders":"","keywords":"Drug; Pharmacology; In vivo; Daunorubicin; Irinotecan; Pharmacokinetics; Medicine; Therapeutic index; Drug interaction; Floxuridine; In vitro; Dosing; Chemotherapy; Chemistry; Cancer; Internal medicine; Fluorouracil; Biology; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01245438690690613,"gpt":0.2571616014258772,"spread":0.2447072145189711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000744642,0.0002887248,0.0004522114,0.0004056835,0.0001123996,0.0001608264,0.0002619782,0.00007303288,0.00004730424],"category_scores_gemma":[0.00001879161,0.0002953744,0.0001088291,0.001123598,0.0001550167,0.0003955554,0.00004198278,0.0001784461,0.000009828717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003964369,"about_ca_system_score_gemma":0.0003048503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007789676,"about_ca_topic_score_gemma":0.0003713473,"domain_scores_codex":[0.9973777,0.0004057539,0.0007013361,0.0004686467,0.0005985426,0.0004480461],"domain_scores_gemma":[0.9986174,0.0002435291,0.0004276254,0.0004064393,0.0002553079,0.00004972454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000310488,0.0002867541,0.007344945,0.0001204463,0.00003379479,0.00002498339,0.0003020738,0.007236474,0.9830363,0.0004584994,0.000002630797,0.0008426611],"study_design_scores_gemma":[0.001786004,0.00004520118,0.005278211,0.0002401131,0.0001286494,0.000007455472,0.00009754409,0.01725967,0.9741758,0.0006483343,0.00002220725,0.000310789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850886,0.008748037,0.004590151,0.0003904922,0.0003093397,0.0007293936,0.0000285127,0.0000726002,0.00004283049],"genre_scores_gemma":[0.9988521,0.0000691649,0.0003861742,0.0003300855,0.00005770639,0.0002027449,0.000006169825,0.00005034761,0.00004555051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01376341,"threshold_uncertainty_score":0.9999498,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2291176625","doi":"10.1158/1535-7163.mct-15-0730","title":"Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models","year":2016,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"","keywords":"Venetoclax; Multiple myeloma; Bortezomib; Cancer research; Bcl-xL; Lenalidomide; Medicine; Pharmacology; Biology; Leukemia; Apoptosis; Immunology; Programmed cell death; Chronic lymphocytic leukemia; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05085372977947655,"gpt":0.3446252469714147,"spread":0.2937715171919382,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003700398,0.0002519537,0.0003627703,0.0001437446,0.0001129999,0.000017837,0.000192114,0.0001383634,0.00005020787],"category_scores_gemma":[0.00009257448,0.000136861,0.00008222678,0.0003172403,0.0001960664,0.00007625078,0.0001315351,0.0002168082,0.000008895876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004418952,"about_ca_system_score_gemma":0.0004110673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001100479,"about_ca_topic_score_gemma":0.00004856081,"domain_scores_codex":[0.9978141,0.0003896283,0.0003151462,0.0004559638,0.0005171629,0.0005079631],"domain_scores_gemma":[0.9988443,0.0002882143,0.00009086449,0.0003619322,0.0001742482,0.0002403859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01335628,0.0002602117,0.01048953,0.00004129914,0.0002565126,0.0001315239,0.0007045269,0.0001700738,0.9377111,0.00001303244,0.0001872851,0.03667867],"study_design_scores_gemma":[0.01021761,0.001272627,0.04798023,0.0003911367,0.0001353793,0.00002406743,0.0001005331,0.006512616,0.9279104,0.0001605982,0.005072264,0.0002225767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889454,0.003409704,0.001896329,0.003294719,0.00007429583,0.002010167,0.0001830834,0.00003873462,0.0001475643],"genre_scores_gemma":[0.9965779,0.0009420507,0.0006395005,0.0007512691,0.00005089333,0.0006091215,0.000009765876,0.00004224913,0.0003772125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0374907,"threshold_uncertainty_score":0.5581031,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123027432","doi":"10.1158/1535-7163.mct-07-0138","title":"Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of Pittsburgh; AstraZeneca","keywords":"Gefitinib; Erlotinib; Head and neck squamous-cell carcinoma; Cancer research; Epithelial–mesenchymal transition; Epidermal growth factor receptor; Biology; Vimentin; Squamous carcinoma; Medicine; Pathology; Oncology; Carcinoma; Internal medicine; Cancer; Head and neck cancer; Immunohistochemistry; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.01401787967718434,"gpt":0.2841128916032479,"spread":0.2700950119260636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000131389,0.0002534485,0.0003561654,0.0001768339,0.00006286964,0.00001646379,0.00006765174,0.0001355799,0.000009034587],"category_scores_gemma":[0.000003012868,0.0002397581,0.00006840125,0.0002638439,0.00007099979,0.00004330474,0.00002317694,0.0001633755,7.319885e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001595767,"about_ca_system_score_gemma":0.000222446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008749553,"about_ca_topic_score_gemma":0.001221001,"domain_scores_codex":[0.9985681,0.00003657003,0.000381129,0.0003984847,0.0002390729,0.0003766639],"domain_scores_gemma":[0.9992692,0.00004652741,0.0001013583,0.0002542706,0.0001344069,0.0001942525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002098185,0.0008241453,0.2000465,0.002004507,0.00008689675,0.0005865589,0.02149535,0.0003090321,0.7690243,0.00004855417,0.00005405588,0.003421838],"study_design_scores_gemma":[0.01009065,0.0009292426,0.3360649,0.0001850391,0.000794812,0.00001243225,0.0006166143,0.0005605457,0.6491538,0.00005003743,0.001198063,0.0003438835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803905,0.01383153,0.002188665,0.0006061532,0.0001107218,0.0009802534,0.0001213219,0.00001820747,0.001752576],"genre_scores_gemma":[0.9954073,0.0002197047,0.002641623,0.001123505,0.00009118448,0.00005580089,0.00002872191,0.00004979346,0.0003824078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1360184,"threshold_uncertainty_score":0.977705,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107867323","doi":"10.1158/1535-7163.mct-04-0077","title":"Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":260,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Jurkat cells; Apoptosis; Biology; Cancer cell; Programmed cell death; Cytotoxic T cell; Cell biology; Cell culture; Cytochrome c; Annexin; Caspase; Molecular biology; Biochemistry; In vitro; Immunology; T cell; Cancer; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.01812805409480726,"gpt":0.2567361298009523,"spread":0.2386080757061451,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006810992,0.0002071598,0.0002544208,0.0001097975,0.000125464,0.00002342376,0.0001283766,0.0002018128,0.00008021012],"category_scores_gemma":[0.000001941239,0.0001944714,0.00005307731,0.0001353157,0.0001471371,0.00008300921,0.00005695515,0.0003099816,0.00001084672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001451784,"about_ca_system_score_gemma":0.00008158974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001147858,"about_ca_topic_score_gemma":0.000309093,"domain_scores_codex":[0.9990818,0.00008823803,0.0001996165,0.0002738671,0.00002952308,0.0003269728],"domain_scores_gemma":[0.9997019,0.00002473772,0.00008074955,0.000136821,0.00003927842,0.00001649901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00005731561,0.0000646747,0.004916108,0.00001827604,0.00006762394,0.000002183039,0.0006959045,0.00005699556,0.9873907,0.0001505706,0.0001527891,0.006426844],"study_design_scores_gemma":[0.0009827983,0.0001288324,0.007225014,0.00002504052,0.00005505978,0.000006064738,0.000200254,0.00001797487,0.9845928,0.00007645801,0.006445737,0.0002439892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894129,0.008973505,0.00008777717,0.0005253848,0.00009447449,0.0001471939,0.00001747219,0.00003359932,0.0007077169],"genre_scores_gemma":[0.9967985,0.0004279396,0.0001037188,0.001454316,0.0000506497,0.00001839915,0.00001786707,0.00002986116,0.001098743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008545565,"threshold_uncertainty_score":0.7930314,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965097080","doi":"10.1158/1535-7163.mct-04-0297","title":"Raf kinase as a target for anticancer therapeutics","year":2005,"lang":"en","type":"review","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"MAPK/ERK pathway; Receptor tyrosine kinase; Kinase; Tyrosine kinase; Cancer research; Signal transduction; Biology; Medicine; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.05591067051033215,"gpt":0.3620443422933081,"spread":0.3061336717829759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002438564,0.0009561764,0.001355752,0.0001316389,0.0001577323,0.00008960727,0.0008062453,0.0009875401,0.00009547202],"category_scores_gemma":[0.00001609642,0.0008477849,0.001179758,0.000233423,0.0001526902,0.0000051411,0.000169137,0.0003743115,0.00004813408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001334101,"about_ca_system_score_gemma":0.001217433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001452974,"about_ca_topic_score_gemma":0.00001666475,"domain_scores_codex":[0.9968376,0.0001966337,0.0007067025,0.001068449,0.0003483076,0.0008423753],"domain_scores_gemma":[0.9979401,0.00004011383,0.0004366282,0.001188524,0.0002103047,0.0001843711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008206576,0.0001249569,0.000002060134,0.002014153,0.001622101,0.0000197067,0.00003281175,0.00001564992,0.009118518,0.0004482844,0.0005853756,0.9859343],"study_design_scores_gemma":[0.000737434,0.0004952103,2.812855e-7,0.0008215375,0.0019751,0.00003573781,0.000008819394,0.00002561212,0.01127334,0.0001771456,0.9834293,0.001020541],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007692914,0.9884716,0.007155266,0.0001573336,0.000799529,0.001842508,0.000568069,0.00005086054,0.0008778781],"genre_scores_gemma":[0.0001400288,0.9881042,0.002350841,0.003487072,0.00145849,0.001297398,0.0008823769,0.0003541313,0.001925444],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9849138,"threshold_uncertainty_score":0.9993973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150625778","doi":"10.1158/1535-7163.mct-06-0174","title":"Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Aging","funders":"","keywords":"Curcumin; Cancer; Pharmacology; Chemistry; In vivo; Cancer cell; Oncogene; Cyclin D1; Phytochemical; In vitro; Cancer research; Biochemistry; Biology; Cell cycle; Apoptosis; Biotechnology","retraction":null,"screen_n_in":null,"score":{"opus":0.02836016943265259,"gpt":0.322280436991616,"spread":0.2939202675589634,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007799758,0.0001499841,0.000284002,0.00006660628,0.00005845534,0.000008246358,0.0001668697,0.0001235651,0.00002333502],"category_scores_gemma":[0.000008126208,0.0001006848,0.0001806843,0.0002706248,0.000265573,0.000002160325,0.00002923192,0.00002848818,6.859917e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002465005,"about_ca_system_score_gemma":0.00009119176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002200795,"about_ca_topic_score_gemma":0.0008183246,"domain_scores_codex":[0.9990904,0.00003573104,0.0002637359,0.0002981346,0.000136774,0.0001752479],"domain_scores_gemma":[0.9993424,0.00004340811,0.0001515878,0.0003127566,0.00009228518,0.00005754692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001070886,0.0001261055,0.002695963,0.000008433634,0.001507701,3.333433e-7,0.00006972862,0.0007583483,0.9276294,0.0001189379,0.00001249059,0.06696543],"study_design_scores_gemma":[0.0004844252,0.00034423,0.02123437,0.000008001319,0.002491969,6.698003e-7,0.0000751072,0.001911562,0.9667264,0.0001532757,0.00643875,0.0001312713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8697414,0.01429997,0.1148736,0.0005535589,0.00003727939,0.0002807986,0.000195527,0.00000575046,0.00001208708],"genre_scores_gemma":[0.9961038,0.002418519,0.0008071604,0.0001262914,0.0001525719,0.0002019762,0.0001289693,0.0000143294,0.00004642266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1263624,"threshold_uncertainty_score":0.4105809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990418094","doi":"10.1158/1535-7163.mct-08-0198","title":"Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":238,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Hypoxia (environmental); Senescence; Biology; Population; Small interfering RNA; Apoptosis; Etoposide; Pharmacology; Daunorubicin; Mitoxantrone; Clonogenic assay; Drug resistance; Hypoxia-inducible factors; Cancer research; Immunology; Cell biology; Chemistry; Cell culture; Medicine; Transfection; Biochemistry; Chemotherapy; Leukemia; Oxygen","retraction":null,"screen_n_in":null,"score":{"opus":0.02930541796033482,"gpt":0.2765230141652082,"spread":0.2472175962048734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001660909,0.0005159693,0.0005084994,0.000103914,0.0003099084,0.0000605007,0.0003466712,0.0003072218,0.00002389892],"category_scores_gemma":[0.00005411216,0.0004887627,0.000141413,0.0004704187,0.000240192,0.00002360598,0.0001282101,0.0002498685,0.000004164912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001188358,"about_ca_system_score_gemma":0.0006076755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000255918,"about_ca_topic_score_gemma":0.0004296701,"domain_scores_codex":[0.9971945,0.0001567936,0.0002913912,0.001036541,0.0005852659,0.0007355494],"domain_scores_gemma":[0.9982442,0.00003317888,0.0002067642,0.0008534269,0.0003096411,0.0003527928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005930483,0.0001163181,0.001452054,0.00002351202,0.0003908265,0.00001806781,0.0005674245,0.000016501,0.9869992,0.00002001286,0.0005357116,0.009267339],"study_design_scores_gemma":[0.001743364,0.0002713541,0.0254715,0.0001040773,0.0001576587,0.00001991561,0.00005704489,0.00002890453,0.9135337,0.00003657093,0.05778732,0.0007886255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873307,0.007951772,0.002204202,0.0008647999,0.0004269356,0.0005627726,0.0001536512,0.00005774198,0.0004473829],"genre_scores_gemma":[0.9893466,0.003305255,0.0005315081,0.005110193,0.0003821603,0.0001292796,0.00002179126,0.0001137482,0.001059492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07346552,"threshold_uncertainty_score":0.9997564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138465485","doi":"10.1158/1535-7163.mct-05-0361","title":"AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Nucleolin; IκB kinase; IκBα; NF-κB; Biology; Phosphorylation; Cancer research; Kinase; Transcription factor; Cell biology; Molecular biology; Signal transduction; Biochemistry; Cytoplasm; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01242050363241252,"gpt":0.2412449483350922,"spread":0.2288244447026797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007920468,0.0003319295,0.0002959991,0.00006569342,0.0001249212,0.00004950557,0.0002009415,0.0002405967,0.00003175395],"category_scores_gemma":[0.000005227465,0.0003202123,0.00009771334,0.0001598888,0.000188038,0.00001533825,0.00009731646,0.0001533067,0.000001614239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004934618,"about_ca_system_score_gemma":0.0001014458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002630349,"about_ca_topic_score_gemma":0.00004824933,"domain_scores_codex":[0.9983878,0.00006597814,0.0003368483,0.0004988241,0.0003320411,0.0003785296],"domain_scores_gemma":[0.9991,0.00001050708,0.0002467316,0.0003915649,0.0001721286,0.00007900963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002091428,0.000101212,0.0007009825,0.00005723433,0.0001849053,0.000003657143,0.0001441311,0.0004180121,0.9951585,0.0001978407,0.0001686313,0.002655775],"study_design_scores_gemma":[0.001271528,0.0002596386,0.0005373785,0.00006153301,0.00008026568,0.000009446037,0.00005170512,0.001163494,0.9816605,0.0001041454,0.01440269,0.0003976829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868448,0.001097079,0.01110175,0.0001712179,0.0000589113,0.0003332671,0.0001251483,0.00003410834,0.0002336874],"genre_scores_gemma":[0.9972395,0.0001010982,0.001399119,0.0007601851,0.0001243388,0.00001792471,0.0001721251,0.0001098126,0.00007589256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01423406,"threshold_uncertainty_score":0.999925,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2756647112","doi":"10.1158/1535-7163.mct-17-0456","title":"Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"MAPK/ERK pathway; Medicine; In vivo; Melanoma; Cancer research; Cancer; Pharmacology; Phosphorylation; Potency; MEK inhibitor; Targeted therapy; In vitro; Internal medicine; Biology; Cell biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03944351150700175,"gpt":0.3106321426094479,"spread":0.2711886311024461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005983174,0.0003350946,0.0002804821,0.00002667272,0.0006913702,0.0001749053,0.0007290062,0.0002290962,0.00001004727],"category_scores_gemma":[0.00006628419,0.0002038801,0.0001312498,0.0001109119,0.0002948581,0.00001594359,0.0002242417,0.0005167582,0.000001683382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007914755,"about_ca_system_score_gemma":0.0004856873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004249576,"about_ca_topic_score_gemma":0.000813902,"domain_scores_codex":[0.9980711,0.0001957709,0.0002758938,0.0006116888,0.0003113881,0.0005341897],"domain_scores_gemma":[0.9984624,0.00005429765,0.000393018,0.0008553367,0.0001618544,0.00007310725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004083852,0.00010762,0.00444972,0.00002244973,0.0002305583,0.00001111606,0.00044132,0.0010566,0.982826,0.00004002536,0.00005906405,0.01034715],"study_design_scores_gemma":[0.00122398,0.0002889523,0.003783432,0.00009224686,0.00007850915,0.000007154632,0.00012631,0.0006650849,0.9742095,0.00003835936,0.01911891,0.0003675025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881299,0.002235091,0.005285225,0.002857035,0.0003002044,0.0007680457,0.0000460005,0.0000191284,0.000359434],"genre_scores_gemma":[0.9971607,0.0001898927,0.0003062163,0.001269556,0.0005307146,0.0003141504,0.00001176661,0.0000701098,0.0001469397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01905984,"threshold_uncertainty_score":0.8313987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2110468894","doi":"10.1158/1535-7163.mct-05-0244","title":"Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":219,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Paclitaxel; Lung cancer; Internal medicine; Oncology; Chemotherapy; Tubulin; Survival analysis; Medicine; Cancer; Prognostic variable; Cancer research; Immunology; Biology; Microtubule","retraction":null,"screen_n_in":null,"score":{"opus":0.00737668742288458,"gpt":0.2444762384879958,"spread":0.2370995510651112,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002372571,0.0003111683,0.0002814647,0.0001126733,0.0000507641,0.00003303943,0.0002115469,0.0002094326,0.000009690228],"category_scores_gemma":[0.000006984221,0.0002843825,0.00005588024,0.0001591195,0.00006072035,0.0000110181,0.0001270236,0.0002595897,8.838913e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001506961,"about_ca_system_score_gemma":0.0001645239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000117649,"about_ca_topic_score_gemma":0.0008007838,"domain_scores_codex":[0.9982633,0.0001579142,0.0003869022,0.0005512382,0.0001836978,0.000456971],"domain_scores_gemma":[0.999261,0.00001870057,0.0001498518,0.0003959793,0.00007598934,0.00009843107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001269029,0.0001695946,0.2645155,0.00005425872,0.00003319944,0.000009845426,0.0003952705,0.002399425,0.7296776,5.340869e-7,0.00004528224,0.001430552],"study_design_scores_gemma":[0.007237911,0.0003576132,0.1272309,0.0003005399,0.00008555203,0.000001501234,0.0001119867,0.0032439,0.8533999,0.000002709791,0.007362727,0.0006647335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938765,0.004067147,0.0009969965,0.0001802926,0.0001002877,0.0006357384,0.00006612253,0.00001307944,0.00006388193],"genre_scores_gemma":[0.9956875,0.0009062394,0.001073711,0.001844697,0.00005918956,0.0001436743,0.0000342043,0.00006973065,0.0001810507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1372845,"threshold_uncertainty_score":0.9999608,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141129148","doi":"10.1158/1535-7163.mct-08-0569","title":"A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":200,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"GLUT1; Programmed cell death; Apoptosis; Receptor; Glucose transporter; Cell biology; Fas ligand; Cancer cell; Intracellular; Glucose uptake; Biology; Mechanism of action; Tumor necrosis factor alpha; Chemistry; Biochemistry; Pharmacology; In vitro; Endocrinology; Cancer; Insulin; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03022342406189453,"gpt":0.2658304461202831,"spread":0.2356070220583886,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009193328,0.000222582,0.000213454,0.00006854718,0.00008064017,0.00001075936,0.0001566272,0.0001670275,0.00001528147],"category_scores_gemma":[0.000006512663,0.0002275041,0.0001530749,0.0001666343,0.00004541255,0.000003058728,0.00007991981,0.00008981382,0.000006758571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002996655,"about_ca_system_score_gemma":0.0001844492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000534418,"about_ca_topic_score_gemma":0.0000113299,"domain_scores_codex":[0.9987909,0.00004303712,0.0002812348,0.0003563523,0.0002454785,0.0002830209],"domain_scores_gemma":[0.999166,0.00000531688,0.0001150037,0.0004045674,0.0001840264,0.0001250508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001050469,0.0001032115,0.00005216098,0.00002277835,0.00006972576,0.00001617778,0.0001437881,0.0009613206,0.9964124,0.00003471484,0.00004167503,0.002036986],"study_design_scores_gemma":[0.0008096157,0.0002067122,0.0002460888,0.00002612196,0.00004074261,0.00001471312,0.00002687558,0.0002016745,0.9852336,0.00001265133,0.01291519,0.0002659844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683478,0.001919458,0.02878645,0.0001346737,0.0001534489,0.0003393157,0.00004793915,0.0000185998,0.0002523113],"genre_scores_gemma":[0.9916422,0.0002413617,0.005853454,0.001830384,0.0001437731,0.00003298723,0.00002524903,0.00005011545,0.0001804199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02329445,"threshold_uncertainty_score":0.927735,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112099873","doi":"10.1158/1535-7163.mct-06-0100","title":"A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis <i>in vivo</i>","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; McGill University Health Centre; McGill University","keywords":"Metastasis; Breast cancer; In vivo; Cancer; Cancer research; Medicine; Metastatic breast cancer; Pathology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01905225245858322,"gpt":0.2994801537536257,"spread":0.2804279012950425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002476168,0.0004057628,0.0005417963,0.0004588447,0.00009669337,0.00007633673,0.0002200623,0.0001845238,0.0004615338],"category_scores_gemma":[0.000009398457,0.0003658863,0.0001883032,0.0008535833,0.0001987213,0.00005776978,0.00009977623,0.0005942776,0.000008965039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003955174,"about_ca_system_score_gemma":0.000474544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004917833,"about_ca_topic_score_gemma":0.0008001783,"domain_scores_codex":[0.9973179,0.000105033,0.0004423151,0.0006484612,0.0007506924,0.0007355744],"domain_scores_gemma":[0.9989601,0.00006254665,0.0001145718,0.0004519307,0.0001956891,0.0002151926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004373722,0.0002604837,0.05753695,0.0001915412,0.0002074219,0.0004666185,0.0001082002,0.0002892865,0.9335489,0.00005688556,0.0003570194,0.006539357],"study_design_scores_gemma":[0.004878836,0.0001960743,0.01415814,0.0004983629,0.0004624232,0.00009050061,0.000110443,0.00418995,0.9644387,0.00009241061,0.01029509,0.0005891118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860235,0.004545531,0.001146549,0.005315424,0.0001070357,0.0008070305,0.0001372422,0.00007058801,0.001847045],"genre_scores_gemma":[0.9938343,0.0008927619,0.0009986444,0.002945849,0.0001150341,0.0002408462,0.00002143919,0.0001197741,0.0008313191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04337881,"threshold_uncertainty_score":0.9998793,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103272465","doi":"10.1158/1535-7163.mct-09-0872","title":"ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Synthetic lethality; Olaparib; Poly ADP ribose polymerase; Cancer research; Mantle cell lymphoma; Biology; DNA damage; Cell culture; DNA repair; Cancer cell; Polymerase; Molecular biology; Cancer; Lymphoma; Gene; DNA; Genetics; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.0142874425754057,"gpt":0.2850526350548136,"spread":0.2707651924794079,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002080007,0.0005123859,0.0005111758,0.0002696699,0.0002051102,0.00007902715,0.0002824998,0.0003131187,0.0005085413],"category_scores_gemma":[0.000008024978,0.0005002079,0.0002979277,0.0006907653,0.0002093035,0.00008240347,0.00008493122,0.0004284063,0.0003819061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002834262,"about_ca_system_score_gemma":0.0005280707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002866544,"about_ca_topic_score_gemma":0.0000497661,"domain_scores_codex":[0.9970256,0.0000839784,0.0005202,0.0007445688,0.0007857566,0.0008398637],"domain_scores_gemma":[0.9980344,0.00005535796,0.0001731349,0.001006484,0.0002501093,0.0004805737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002643262,0.0003680471,0.0004989692,0.00005910833,0.00009391705,0.0001617531,0.0006072163,0.00002830434,0.9717165,0.0001550385,0.001544688,0.02450213],"study_design_scores_gemma":[0.002968231,0.0002734608,0.0005041019,0.0000801022,0.0001880482,0.00007386675,0.0001206498,0.0001128975,0.8895705,0.0001166607,0.1054699,0.0005215601],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751472,0.005535417,0.002363018,0.006579779,0.002916826,0.0008928552,0.0001263048,0.0002783109,0.006160237],"genre_scores_gemma":[0.9703413,0.0003264773,0.002970567,0.02375386,0.000910365,0.0001276352,0.00002437294,0.0001781988,0.001367168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1039252,"threshold_uncertainty_score":0.999745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114788766","doi":"10.1158/1535-7163.mct-06-0417","title":"Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; University of British Columbia Hospital","funders":"","keywords":"Hsp27; Gene knockdown; Paclitaxel; Cancer research; Bladder cancer; Heat shock protein; Apoptosis; Cell growth; Cancer cell; In vivo; Biology; Cancer; Medicine; Hsp70; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02024863063210556,"gpt":0.3283580341170095,"spread":0.308109403484904,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004533808,0.0003888058,0.000317522,0.0001862685,0.0001633449,0.00007152359,0.0003227885,0.0002380042,0.00009519947],"category_scores_gemma":[0.00001020056,0.0003908538,0.0001115801,0.0003614266,0.0002723045,0.00001109355,0.0001040163,0.0003309342,0.000001773593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000134144,"about_ca_system_score_gemma":0.0003031218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000860016,"about_ca_topic_score_gemma":0.0006216656,"domain_scores_codex":[0.9975785,0.0001457487,0.0004121712,0.0006864401,0.0003899329,0.000787201],"domain_scores_gemma":[0.9990678,0.00002096438,0.0001174005,0.0004826292,0.0001558292,0.0001553077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001984567,0.0001187335,0.005113292,0.00006662407,0.0001538892,0.00003587154,0.0001978257,0.0002684994,0.9858876,0.00003227172,0.00001487857,0.007911985],"study_design_scores_gemma":[0.001353317,0.0001902668,0.001461664,0.00008135153,0.00002721689,0.000003445486,0.00006506986,0.0003515874,0.9910711,0.0000911842,0.004836763,0.0004670045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801936,0.009625945,0.008610809,0.0005634535,0.00008879635,0.0006769964,0.00002431828,0.00002548777,0.0001905737],"genre_scores_gemma":[0.9928028,0.001049019,0.001458392,0.004189697,0.0001688142,0.00009194981,0.00001245733,0.0001274842,0.00009940387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01260916,"threshold_uncertainty_score":0.9998543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150186278","doi":"10.1158/1535-7163.271.4.2","title":"Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"AKT2; Protein kinase B; AKT1; AKT3; PI3K/AKT/mTOR pathway; Pleckstrin homology domain; Biology; Cancer research; Cell biology; Kinase; Phosphorylation; Signal transduction; Proto-Oncogene Proteins c-akt; Cell growth; Chemistry; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01456171744743731,"gpt":0.2658808507582696,"spread":0.2513191333108322,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001321332,0.0002955923,0.000248568,0.00008290009,0.00006910862,0.00002787301,0.0001725144,0.0001705031,0.00004542174],"category_scores_gemma":[0.000009093852,0.0003314833,0.0001254161,0.0003231747,0.00008884099,0.000008832764,0.0000613366,0.0001479745,0.00001559857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001959563,"about_ca_system_score_gemma":0.0001568189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004940632,"about_ca_topic_score_gemma":0.00002567606,"domain_scores_codex":[0.9982945,0.000107172,0.0003495611,0.0005373947,0.0003342417,0.0003771173],"domain_scores_gemma":[0.9989805,0.00001572628,0.0001819217,0.0004064995,0.0002991447,0.0001162312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001631373,0.00009711109,0.0001014089,0.00002845777,0.0001082576,0.000003127447,0.0001705448,0.01970606,0.97276,0.00002008551,0.003566833,0.003274969],"study_design_scores_gemma":[0.0007551392,0.0003282396,0.000089584,0.00003912051,0.00007350339,0.000003558441,0.00004641296,0.0005278525,0.9456997,0.00003644927,0.05204132,0.0003591042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9588639,0.00664119,0.03200489,0.0005759213,0.0002379743,0.0004747225,0.0001333481,0.00002823899,0.001039788],"genre_scores_gemma":[0.9922395,0.0003808432,0.00218226,0.004384096,0.0002717391,0.0000540009,0.0001403533,0.00008875171,0.000258423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04847449,"threshold_uncertainty_score":0.9999137,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035386385","doi":"10.1158/1535-7163.mct-05-0128","title":"Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Temozolomide; Poly ADP ribose polymerase; Glioma; DNA repair; Pharmacology; O-6-methylguanine-DNA methyltransferase; Cancer research; PARP inhibitor; Growth inhibition; Medicine; Chemistry; Polymerase; DNA; Methyltransferase; Cell growth; Biochemistry; Methylation","retraction":null,"screen_n_in":null,"score":{"opus":0.02422417574187588,"gpt":0.3031121217187833,"spread":0.2788879459769075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004199092,0.0005253796,0.0006621109,0.0004667103,0.000187403,0.00006777253,0.0001900911,0.0002979311,0.0003284],"category_scores_gemma":[0.00001922104,0.0005284621,0.000390049,0.001150422,0.0002987979,0.0001672897,0.00005671057,0.0004646684,0.00006240904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001211639,"about_ca_system_score_gemma":0.0004624778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002427244,"about_ca_topic_score_gemma":0.0004926684,"domain_scores_codex":[0.9962441,0.0002156997,0.0009088927,0.0008930043,0.0008702294,0.0008680292],"domain_scores_gemma":[0.9982079,0.00005625988,0.0002998238,0.001008008,0.0001879252,0.0002400591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001810455,0.0007319838,0.002122229,0.0002275534,0.000357555,0.0008847129,0.001951916,0.0001073552,0.9797226,0.001058859,0.002679011,0.008345731],"study_design_scores_gemma":[0.005375084,0.0002257843,0.001534437,0.001086765,0.00023056,0.0001332805,0.0002576039,0.0002809877,0.8047727,0.0004100375,0.1850337,0.0006590856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9050052,0.06859414,0.001441898,0.02044253,0.0004434666,0.00113283,0.0001294312,0.0004267259,0.002383735],"genre_scores_gemma":[0.9725727,0.001419327,0.004645849,0.01913498,0.0004968033,0.0003727447,0.00006128602,0.0001522153,0.00114414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1823547,"threshold_uncertainty_score":0.9997167,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128701004","doi":"10.1158/1535-7163.mct-08-0126","title":"SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Bosutinib; Proto-oncogene tyrosine-protein kinase Src; Focal adhesion; Cancer research; Src family kinase; Tyrosine kinase; Cancer cell; Kinase; Cancer; Cell biology; Biology; Chemistry; Signal transduction; Dasatinib","retraction":null,"screen_n_in":null,"score":{"opus":0.02368753285909452,"gpt":0.2706735943568307,"spread":0.2469860614977362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008475583,0.0002151243,0.0001976762,0.00006367576,0.0001423696,0.00001987763,0.0001184718,0.0001752838,0.00003278068],"category_scores_gemma":[0.000004144926,0.0002114711,0.00009399097,0.0001287531,0.0001766367,0.000008815268,0.00007657172,0.00009308533,5.957465e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002569484,"about_ca_system_score_gemma":0.0001346924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003660939,"about_ca_topic_score_gemma":0.0001527049,"domain_scores_codex":[0.998873,0.00005493434,0.0002764827,0.0003548348,0.0002220103,0.0002187456],"domain_scores_gemma":[0.9992746,0.000005808435,0.0001633762,0.0002927607,0.0001817256,0.00008171576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008791071,0.0001064698,0.002339867,0.00005835275,0.00008546452,0.000006450685,0.0001448001,0.0003490684,0.9946094,0.0000699061,0.00008146342,0.002060867],"study_design_scores_gemma":[0.000947653,0.0001136773,0.002656054,0.0000806661,0.00006319198,0.00002375579,0.00002682938,0.0002167611,0.9895332,0.00003514754,0.006054539,0.0002484647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882959,0.008142825,0.002659173,0.0003191375,0.0001017959,0.0002698778,0.0001508164,0.00001528695,0.00004526295],"genre_scores_gemma":[0.9966423,0.001908877,0.0004351095,0.0006053394,0.000154121,0.00005430467,0.00007396474,0.00003896224,0.00008701209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008346484,"threshold_uncertainty_score":0.8623542,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118566193","doi":"10.1158/1535-7163.mct-05-0030","title":"The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Sesquiterpenes and Asteraceae Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Parthenolide; Docetaxel; In vivo; Medicine; Pharmacology; Cancer research; Sesquiterpene lactone; Metastasis; Apoptosis; In vitro; Cancer; Internal medicine; Chemistry; Biology; Sesquiterpene; Biochemistry; Stereochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01756894445858474,"gpt":0.2848227319139941,"spread":0.2672537874554093,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001697334,0.0001926303,0.0002255466,0.00005528243,0.00006073649,0.00003349458,0.0001498255,0.00006198543,0.000002195059],"category_scores_gemma":[0.000002945234,0.0001351086,0.00004525312,0.0001577224,0.0001550075,0.00001263379,0.00008623704,0.00009150354,1.151241e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002983845,"about_ca_system_score_gemma":0.00008278895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000246465,"about_ca_topic_score_gemma":0.003124488,"domain_scores_codex":[0.9989634,0.00007092251,0.0002530591,0.0002789552,0.0001613026,0.000272426],"domain_scores_gemma":[0.9995261,0.00001582867,0.0001222811,0.0002111689,0.00009318346,0.00003142094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005507633,0.0001584835,0.01141256,0.00003125629,0.0002994907,0.000002052359,0.0006874618,0.006198941,0.8716538,0.0001213639,0.000004524526,0.1088793],"study_design_scores_gemma":[0.005838763,0.0005043646,0.03935158,0.0002384429,0.0002780123,0.00001578453,0.001459818,0.02261907,0.9235479,0.0003289518,0.004982036,0.0008353117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811722,0.0160192,0.0003505712,0.00207404,0.0000380563,0.0002295711,0.00005990728,0.000004173175,0.00005228628],"genre_scores_gemma":[0.9917156,0.007377166,0.0002956242,0.000372595,0.00003565325,0.0001051829,0.000008617129,0.00002679069,0.00006274282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.108044,"threshold_uncertainty_score":0.5509571,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144520265","doi":"10.1158/1535-7163.mct-05-0539","title":"Promise of vitamin D analogues in the treatment of hyperproliferative conditions","year":2006,"lang":"en","type":"review","venue":"Molecular Cancer Therapeutics","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Calcitriol; Vitamin D and neurology; Calcitriol receptor; Pharmacology; Cancer; Cancer research; Steroid hormone; Medicine; Calcipotriol; Angiogenesis; Endocrinology; Internal medicine; Biology; Psoriasis; Hormone; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.09284472894735561,"gpt":0.4210077713324955,"spread":0.3281630423851399,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001340591,0.0003255973,0.001582025,0.0002416928,0.00003626621,0.000006514983,0.000176394,0.0001515242,0.00001252035],"category_scores_gemma":[0.00001307488,0.0001789256,0.000479258,0.0005215284,0.000336335,0.00001295327,0.00001940231,0.0001952872,0.000001800926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002884769,"about_ca_system_score_gemma":0.0005255144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001486876,"about_ca_topic_score_gemma":0.00009486711,"domain_scores_codex":[0.9982239,0.000324182,0.0005513186,0.0002490636,0.0004089976,0.0002425445],"domain_scores_gemma":[0.9988898,0.0001750488,0.000259252,0.0004790232,0.0001669534,0.00002991734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005821877,0.00347227,0.00055557,0.01941658,0.005512121,0.0003606546,0.00351967,0.0000154496,0.0007889424,0.0003416016,0.0002275989,0.9657313],"study_design_scores_gemma":[0.002129404,0.002234755,0.0009532064,0.009453551,0.006420694,0.00003749661,0.0003656517,0.00001542903,0.001783801,0.00009541409,0.9761755,0.0003351331],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001676451,0.9949892,0.0000188289,0.000173083,0.00003577662,0.002270711,0.0003955984,0.000007321319,0.0004329926],"genre_scores_gemma":[0.005966297,0.9922712,0.00007928274,0.00007041359,0.00005263033,0.001134196,0.0002087749,0.00003858362,0.0001786384],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9759479,"threshold_uncertainty_score":0.7296375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165769610","doi":"10.1158/1535-7163.1239.3.10","title":"The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice","year":2004,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Sulforaphane; Apoptosis; Isothiocyanate; Oxidative stress; Cell cycle; Glutathione; Cyclin B1; Pancreatic cancer; Molecular biology; Growth inhibition; Biology; Cyclin-dependent kinase 1; Chemistry; Cancer research; Biochemistry; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.009102891551533127,"gpt":0.2328250037178343,"spread":0.2237221121663011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001421168,0.000299489,0.0003258996,0.00006772578,0.0001058385,0.000029863,0.0002359018,0.0001207661,0.000001921276],"category_scores_gemma":[0.000007142074,0.0002643037,0.00006499967,0.000162553,0.0003032879,0.000009392385,0.0001604851,0.0002044335,2.111593e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007048171,"about_ca_system_score_gemma":0.0001088063,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009626669,"about_ca_topic_score_gemma":0.0007037715,"domain_scores_codex":[0.9984995,0.0001065469,0.0003873138,0.0004660794,0.0001415306,0.0003990119],"domain_scores_gemma":[0.9993292,0.00002437724,0.000207832,0.0002715606,0.0001001264,0.00006692297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002032953,0.0001897135,0.003149576,0.0001236184,0.00009646677,0.00000495929,0.000727198,0.001091737,0.994019,0.00007500669,0.000002888345,0.000316543],"study_design_scores_gemma":[0.002166142,0.0002280035,0.003199544,0.0001405004,0.00005094551,0.000001262887,0.0004917107,0.00005117702,0.992189,0.001123324,0.00004741486,0.0003109029],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9650972,0.03388634,0.00006749063,0.0001350294,0.00008312937,0.0004509025,0.0002081918,0.00000535444,0.00006632562],"genre_scores_gemma":[0.9886169,0.01068598,0.0001313361,0.0003427745,0.0000220736,0.00009528563,0.0000553754,0.00003940493,0.00001081347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02351972,"threshold_uncertainty_score":0.9999809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2139966699","doi":"10.1158/1535-7163.mct-10-0677","title":"Notch Signaling Pathway as a Therapeutic Target in Breast Cancer","year":2010,"lang":"en","type":"review","venue":"Molecular Cancer Therapeutics","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Research Resources; University of California, Davis; Cancer Research Coordinating Committee; Office of Research and Development; Purdue University","keywords":"Notch signaling pathway; Cancer; Breast cancer; Signal transduction; Cancer research; Medicine; Disease; Biology; Bioinformatics; Pharmacology; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02217025574261026,"gpt":0.314756041743817,"spread":0.2925857860012067,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002612933,0.0006834406,0.00091933,0.0001632002,0.0000977979,0.00004247757,0.0005088499,0.001298778,0.0001647919],"category_scores_gemma":[0.000004119412,0.000599096,0.0004320746,0.000345,0.0001448118,0.000005554582,0.0001408022,0.0006561848,0.0000316883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001340517,"about_ca_system_score_gemma":0.00118549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006768169,"about_ca_topic_score_gemma":0.0001034945,"domain_scores_codex":[0.9974853,0.000265975,0.00059751,0.0008464654,0.0002307644,0.0005739731],"domain_scores_gemma":[0.9989026,0.00001829552,0.000326938,0.0005533088,0.00009762744,0.0001011942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005100472,0.00007562876,0.0001985269,0.0006338883,0.0005332293,0.00002105206,0.00004077148,0.00003969641,0.114232,0.00005123229,0.00001757665,0.8841054],"study_design_scores_gemma":[0.0003684633,0.00005223437,0.00005276557,0.001092442,0.0002809344,0.00007855297,0.000009132379,0.000007655085,0.03050473,0.0001760326,0.966599,0.0007780858],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002502429,0.9951951,0.0002357817,0.0002154914,0.0006827615,0.0007268258,0.0002166246,0.00002365616,0.0002013133],"genre_scores_gemma":[0.005370378,0.9906407,0.0002407646,0.001627477,0.0003346452,0.0005791981,0.0006045846,0.0001473018,0.0004549761],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9665814,"threshold_uncertainty_score":0.9999977,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147471000","doi":"10.1158/1535-7163.mct-05-0082","title":"Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non–small cell lung cancer cells","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Urokinase receptor; Cancer research; Metastasis; Angiogenesis; Matrix metalloproteinase; Zymography; Lung cancer; Biology; Cancer cell; Cancer; Molecular biology; Pathology; Chemistry; Plasminogen activator; Medicine; Internal medicine; Endocrinology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.008975766653876045,"gpt":0.2287185695020593,"spread":0.2197428028481833,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001221328,0.0002251672,0.0002896067,0.00008992943,0.00002959649,0.000009635708,0.00008375617,0.0001564,0.00001257263],"category_scores_gemma":[0.000003517236,0.0002259123,0.00008178373,0.0001649817,0.00009285697,0.000009813573,0.00004732016,0.00008420394,2.404558e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001843985,"about_ca_system_score_gemma":0.00009215406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002451655,"about_ca_topic_score_gemma":0.0001274777,"domain_scores_codex":[0.9988159,0.00008627097,0.0003482133,0.0003571356,0.0001518574,0.0002406371],"domain_scores_gemma":[0.9995313,0.00000914954,0.0001016621,0.0001910419,0.00008813365,0.0000787036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001265995,0.0001126324,0.0009839995,0.0001883402,0.0001098163,0.000006500057,0.0001631646,0.00003951156,0.9970071,0.000007126513,0.00006497874,0.001190253],"study_design_scores_gemma":[0.001372754,0.0001691243,0.0001500997,0.00007963459,0.0001849569,0.000002943186,0.00004065832,0.0001713025,0.9970791,0.00001484053,0.0004948847,0.0002397211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9516422,0.04554943,0.001879406,0.0001133789,0.00004189718,0.0004023178,0.0003433976,0.00000508928,0.00002287765],"genre_scores_gemma":[0.9859743,0.01253994,0.0004389152,0.0008425547,0.00003834246,0.00006214116,0.00005311503,0.0000407896,0.000009884719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03433211,"threshold_uncertainty_score":0.9212436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166435610","doi":"10.1158/1535-7163.mct-13-0032","title":"Synergistic Targeting of PI3K/AKT Pathway and Androgen Receptor Axis Significantly Delays Castration-Resistant Prostate Cancer Progression <i>In Vivo</i>","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Bicalutamide; LNCaP; Prostate cancer; Androgen receptor; Protein kinase B; Antiandrogen; Cancer research; In vivo; PI3K/AKT/mTOR pathway; Medicine; Growth inhibition; Androgen; Internal medicine; Pharmacology; Endocrinology; Cell growth; Cancer; Apoptosis; Chemistry; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02192626339959827,"gpt":0.3056647247005957,"spread":0.2837384613009974,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001735549,0.0002622982,0.0003915486,0.0001250779,0.00008846534,0.00004269936,0.00009604353,0.0001203427,0.0002760998],"category_scores_gemma":[0.00001346547,0.0002000755,0.00007422073,0.0003465416,0.0001947727,0.00009484659,0.00004304207,0.0002167969,0.000003800561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002251932,"about_ca_system_score_gemma":0.0004783697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001038586,"about_ca_topic_score_gemma":0.0001041718,"domain_scores_codex":[0.9981289,0.00009626464,0.0004336478,0.0004144127,0.0004506398,0.0004761158],"domain_scores_gemma":[0.9990785,0.00004166005,0.0001664013,0.000242042,0.0003014837,0.0001699445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005503275,0.0001625836,0.01421686,0.0003391755,0.0002103391,0.00006634318,0.0008724178,0.00006437539,0.9550372,0.00004192192,0.000140344,0.02829814],"study_design_scores_gemma":[0.002700712,0.0006244005,0.001451856,0.0006452801,0.0001399614,0.000003461182,0.0004306131,0.0008221277,0.9888713,0.0001394953,0.003890912,0.0002798481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9653983,0.03087084,0.00007826467,0.001430382,0.0001063484,0.001651785,0.0001491329,0.00003302072,0.000281935],"genre_scores_gemma":[0.9929308,0.004699892,0.0007717267,0.0002844917,0.00005409049,0.0007427852,0.00004103627,0.00005760545,0.0004175566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03383416,"threshold_uncertainty_score":0.8158842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136405771","doi":"10.1158/1535-7163.mct-05-0229","title":"Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"AP site; Molecular biology; Melanoma; DNA-(apurinic or apyrimidinic site) lyase; Apoptosis; Transcription factor; Biology; DNA damage; Cancer research; Chemistry; Resveratrol; Base excision repair; DNA; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01258426550445587,"gpt":0.3051051727510787,"spread":0.2925209072466229,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000219008,0.000169593,0.0001760352,0.00005736774,0.00008204974,0.00002041529,0.0004422719,0.0001355901,0.000009725018],"category_scores_gemma":[0.00001110285,0.0001104543,0.0001238765,0.0001768976,0.0001443879,0.0000113849,0.0000939476,0.0001689392,1.852131e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002222444,"about_ca_system_score_gemma":0.00007406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007164672,"about_ca_topic_score_gemma":0.0002276502,"domain_scores_codex":[0.9985573,0.0002572181,0.000492692,0.0002596079,0.0002560669,0.0001771308],"domain_scores_gemma":[0.998996,0.00001443188,0.0002207939,0.0006749802,0.00006893263,0.00002487769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00005662931,0.0001248636,0.001887115,0.00002781933,0.00003911024,4.579193e-7,0.0009873816,0.003731428,0.9907548,0.0001578474,0.000003766716,0.002228717],"study_design_scores_gemma":[0.0006894781,0.0001256153,0.02711344,0.00004631702,0.00005523325,0.000004962403,0.000321697,0.0005918529,0.9703032,0.0001555254,0.0004750276,0.0001175985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947491,0.00350178,0.000769566,0.0003617863,0.0001072568,0.0004343256,0.00003324654,0.000003374112,0.00003959061],"genre_scores_gemma":[0.9991776,0.0003121278,0.00005048893,0.0002829073,0.0000750609,0.00003934763,0.00001093483,0.00002543494,0.00002614301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02522632,"threshold_uncertainty_score":0.4504198,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151876400","doi":"10.1158/1535-7163.mct-12-0950","title":"RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Université Laval","keywords":"Olaparib; PARP inhibitor; Cancer research; DNA damage; Cancer; DNA repair; Medicine; Biology; Poly ADP ribose polymerase; Internal medicine; DNA; Polymerase","retraction":null,"screen_n_in":null,"score":{"opus":0.02604159606197083,"gpt":0.2989487605357953,"spread":0.2729071644738245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001965551,0.0004627908,0.0005216924,0.0001420435,0.0002368843,0.0001150263,0.000282634,0.00019374,0.000476981],"category_scores_gemma":[0.000009743449,0.0003403622,0.0002530974,0.0006737243,0.0001888706,0.00008692147,0.00009358105,0.0004964804,0.0004647704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007256095,"about_ca_system_score_gemma":0.0003425025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001020628,"about_ca_topic_score_gemma":0.0001485372,"domain_scores_codex":[0.9971171,0.0001717639,0.0004736556,0.0006610906,0.0008274348,0.000748941],"domain_scores_gemma":[0.9978583,0.0000709841,0.0002325825,0.0009088917,0.0006043159,0.0003248579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003056231,0.0002209142,0.0009325611,0.00006937018,0.000648218,0.00007019821,0.002177682,0.002398475,0.950589,0.0002359948,0.02361811,0.01873383],"study_design_scores_gemma":[0.001899186,0.0002146746,0.003197938,0.0003263512,0.0002897356,0.00002621294,0.0005101639,0.0006642608,0.7941439,0.0001016601,0.1981419,0.0004840413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9028069,0.007635072,0.005643385,0.07641435,0.002519614,0.003176952,0.000244401,0.0002422722,0.001317092],"genre_scores_gemma":[0.9201176,0.001162459,0.0004995365,0.0749388,0.0007506012,0.001328462,0.00001437268,0.0001296662,0.001058565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1745238,"threshold_uncertainty_score":0.9999048,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151135547","doi":"10.1158/1535-7163.mct-08-0136","title":"Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of California, Los Angeles; U.S. Department of Veterans Affairs; U.S. Department of Defense","keywords":"Prostate cancer; Androgen; Apoptosis; Cancer; Cancer research; Internal medicine; Prostate; Endocrinology; Viability assay; Medicine; Chemistry; Hormone; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03845215773367282,"gpt":0.301945314570622,"spread":0.2634931568369492,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001485012,0.0006041987,0.0005817991,0.0002169633,0.0009579465,0.0001121434,0.0004558719,0.0003219623,0.0003080741],"category_scores_gemma":[0.000004713565,0.0005873998,0.0002773472,0.000520923,0.0001373236,0.0003357577,0.00009992891,0.0007200658,0.00006484757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007441445,"about_ca_system_score_gemma":0.000233404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003008637,"about_ca_topic_score_gemma":0.0004028668,"domain_scores_codex":[0.9962161,0.0001944071,0.0006530599,0.0008332661,0.0009759188,0.001127242],"domain_scores_gemma":[0.9984305,0.00003257954,0.0003152112,0.0005826605,0.0003474627,0.0002916106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002635254,0.001619651,0.005031637,0.0006213824,0.001673129,0.001219801,0.02773064,0.000925729,0.8730058,0.01221079,0.000539873,0.07278629],"study_design_scores_gemma":[0.007839039,0.001141459,0.005843827,0.0005977241,0.0006550659,0.0004605862,0.0004860665,0.0025998,0.9256072,0.0127121,0.03943048,0.002626634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757391,0.01387869,0.0009009964,0.005107089,0.001615882,0.001188238,0.0004559599,0.0003601911,0.0007538449],"genre_scores_gemma":[0.9807213,0.008539085,0.0006678878,0.009290232,0.0001644203,0.0001813575,0.00002374914,0.0002212857,0.0001906889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07015965,"threshold_uncertainty_score":0.9996578,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2265903980","doi":"10.1158/1535-7163.223.3.3","title":"Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both<i>in vitro</i>and<i>in vivo</i>","year":2004,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"National Cancer Institute; Canadian Prostate Cancer Research Initiative","keywords":"Clusterin; Cancer research; Paclitaxel; Lung cancer; In vivo; A549 cell; Gene silencing; Apoptosis; Cancer; Small interfering RNA; Biology; Medicine; Molecular biology; Pharmacology; Cell culture; Pathology; Transfection; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01602499426812858,"gpt":0.2802923743056767,"spread":0.2642673800375481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000239033,0.000384202,0.0005514455,0.0002279464,0.00007394754,0.00003249697,0.0001602736,0.0001904792,0.00008192778],"category_scores_gemma":[0.000009213427,0.0003696189,0.0001470713,0.0002760401,0.0002299156,0.00005040306,0.00009561513,0.0003246403,0.000005120241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004947286,"about_ca_system_score_gemma":0.0001772038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000166011,"about_ca_topic_score_gemma":0.00007345094,"domain_scores_codex":[0.9978127,0.0001378932,0.0005028383,0.0006028155,0.0003031316,0.0006405492],"domain_scores_gemma":[0.9991434,0.00005274136,0.0001255028,0.0004723661,0.00005702414,0.0001489793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007228353,0.0001682044,0.008935673,0.0001922671,0.00007383744,0.001140361,0.0007033985,0.0006576179,0.9863634,0.00003646615,0.00001210534,0.0009938815],"study_design_scores_gemma":[0.008626861,0.0001246173,0.01161058,0.0003940024,0.0001511887,0.0000405479,0.0001579452,0.0008725185,0.9762476,0.0004006768,0.0008884603,0.0004849924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854716,0.007621903,0.001980735,0.003634645,0.0001872646,0.0007193097,0.00003725641,0.00009147218,0.0002558345],"genre_scores_gemma":[0.9867671,0.0002231638,0.002040223,0.01057039,0.00009637724,0.0001004893,0.00001121583,0.0001226465,0.00006841894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01011575,"threshold_uncertainty_score":0.9998756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168586185","doi":"10.1158/1535-7163.mct-08-0374","title":"HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Liver physiology and pathology","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"Max Kade Foundation","keywords":"Cancer research; Protein kinase B; Tyrosine kinase; MAPK/ERK pathway; Receptor tyrosine kinase; PI3K/AKT/mTOR pathway; Biology; Kinase; Signal transduction; Chemistry; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03595320280640982,"gpt":0.2968964523811407,"spread":0.2609432495747309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001122263,0.0002521196,0.0003928065,0.0002426069,0.00009014221,0.000006522682,0.00007642523,0.0002148896,0.0001958303],"category_scores_gemma":[0.00001355807,0.000245366,0.00008923005,0.0007164636,0.0001336022,0.00006628112,0.00003234244,0.0003080925,0.00001881197],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003586227,"about_ca_system_score_gemma":0.0003231075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002746669,"about_ca_topic_score_gemma":0.000172157,"domain_scores_codex":[0.9984322,0.0001996921,0.0003053268,0.0004382862,0.0002399142,0.0003845997],"domain_scores_gemma":[0.9991698,0.00003767623,0.0001189225,0.000347333,0.0001969397,0.0001292969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001141969,0.0001941701,0.003667208,0.0000449866,0.0001364374,0.0004651033,0.0007060511,0.0005912255,0.9906343,0.000087177,0.00042956,0.001901779],"study_design_scores_gemma":[0.002575939,0.0003905625,0.02526267,0.000198077,0.000180545,0.00002004583,0.00005476026,0.00003828547,0.9623095,0.00010122,0.008601191,0.000267178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934325,0.00210396,0.001858262,0.001358084,0.0002213825,0.0005991664,0.00008104242,0.0000519119,0.0002937284],"genre_scores_gemma":[0.9851149,0.000917379,0.00110632,0.01196039,0.0001219182,0.0002117452,0.00009008206,0.00004717485,0.000430078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02832481,"threshold_uncertainty_score":0.9999999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111954625","doi":"10.1158/1535-7163.mct-10-0590","title":"Reovirus Virotherapy Overrides Tumor Antigen Presentation Evasion and Promotes Protective Antitumor Immunity","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Oncolytic virus; Antigen; Cancer research; Tumor microenvironment; Virotherapy; Immunology; Biology; Immunotherapy; Dendritic cell; Antigen presentation; Tumor antigen; T cell","retraction":null,"screen_n_in":null,"score":{"opus":0.03400446285726151,"gpt":0.3567167288196482,"spread":0.3227122659623867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002937281,0.0001768132,0.0002893436,0.00009162416,0.0001291958,0.00003119616,0.000102925,0.0000857247,0.00008512344],"category_scores_gemma":[0.00008800934,0.0001479031,0.00007533545,0.0001263538,0.0002506915,0.00009148518,0.00005232284,0.000531211,0.000004610547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004573198,"about_ca_system_score_gemma":0.0001099068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007585178,"about_ca_topic_score_gemma":0.0001813644,"domain_scores_codex":[0.9986951,0.0001895889,0.0002160936,0.0002953582,0.0002378444,0.0003660025],"domain_scores_gemma":[0.9993183,0.00001713299,0.00008631669,0.000306203,0.0001332416,0.0001387915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006079115,0.0001002274,0.04837338,0.00005888852,0.0001388095,0.00006617976,0.0001538053,0.000002391047,0.9287881,0.00005376289,0.00002002213,0.02163654],"study_design_scores_gemma":[0.002595191,0.001478759,0.3191676,0.0001450793,0.00007101324,0.0002256289,0.00008439298,0.001345753,0.6671376,0.00137601,0.00613697,0.0002360099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932861,0.001600942,0.001784548,0.001908483,0.0001177278,0.001117739,0.00002027171,0.0000513272,0.0001128053],"genre_scores_gemma":[0.995034,0.00127491,0.001392735,0.001926715,0.0001059366,0.000162093,0.00001497392,0.00003800492,0.00005059281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2707942,"threshold_uncertainty_score":0.6031312,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980976141","doi":"10.1158/1535-7163.mct-08-0762","title":"Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Saffron Plant Research Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Crocetin; In vivo; Pancreatic cancer; Cell growth; In vitro; Apoptosis; Cancer research; Cancer; Proliferating cell nuclear antigen; Nude mouse; Cell cycle; Chemistry; Molecular biology; Biology; Pharmacology; Biochemistry; Internal medicine; Medicine; Carotenoid","retraction":null,"screen_n_in":null,"score":{"opus":0.02945616339086384,"gpt":0.3422801332368997,"spread":0.3128239698460358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001458644,0.0002180779,0.0003161056,0.0001093443,0.00007220154,0.00003569452,0.0000672845,0.00007623991,0.00001746917],"category_scores_gemma":[0.00001243314,0.0001766687,0.00004221487,0.0002055157,0.00006256477,0.00007633746,0.00003499233,0.0002417648,0.000001838886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002184532,"about_ca_system_score_gemma":0.0002414608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001395323,"about_ca_topic_score_gemma":0.0002338731,"domain_scores_codex":[0.9985536,0.00005663047,0.0002406083,0.0003301148,0.0004252207,0.0003938522],"domain_scores_gemma":[0.9994834,0.00001591128,0.00007218,0.000193735,0.0001252072,0.0001095379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008013665,0.0004246416,0.02570329,0.0003058507,0.00009221524,0.00008810911,0.001822811,0.0004777237,0.9462451,0.00005376937,0.0001465382,0.02383862],"study_design_scores_gemma":[0.004026698,0.0006720427,0.008446706,0.0007207433,0.0002266894,0.00002077604,0.0001840612,0.05140177,0.9329048,0.0003411109,0.0006417893,0.0004128245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691906,0.02509294,0.0005010228,0.00370583,0.00001802204,0.001032201,0.0000208628,0.00005863469,0.0003798915],"genre_scores_gemma":[0.9880314,0.006237898,0.001270103,0.003592495,0.00003968803,0.0002741968,0.00001262109,0.0000286765,0.0005129048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05092405,"threshold_uncertainty_score":0.7204341,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101599998","doi":"10.1158/1535-7163.mct-09-0243","title":"Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations <i>in vitro</i> and <i>in vivo</i>","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Irinotecan; Cisplatin; In vivo; Pharmacology; Drug; In vitro; Cytotoxicity; Chemistry; Medicine; Liposome; Chemotherapy; Cancer; Biology; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01875205029635636,"gpt":0.3266822291234521,"spread":0.3079301788270958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001953414,0.0001508376,0.0003472312,0.0001589541,0.00004149247,0.0000162614,0.00006293927,0.00004682623,0.000006813242],"category_scores_gemma":[0.00001477325,0.0001425803,0.00003393763,0.0002658544,0.0001346956,0.00006603387,0.00004397821,0.0002362592,2.255074e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001524716,"about_ca_system_score_gemma":0.0001293024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000354561,"about_ca_topic_score_gemma":0.000357149,"domain_scores_codex":[0.9988867,0.00007280699,0.0002062114,0.0002615352,0.0003199568,0.0002528097],"domain_scores_gemma":[0.999543,0.00004675838,0.0000680457,0.0002043219,0.00007173561,0.00006616513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004387306,0.0003398665,0.007252231,0.000110475,0.00006645879,0.0000689388,0.0005856142,0.00003868677,0.9716805,0.0002237907,0.00002270883,0.01917202],"study_design_scores_gemma":[0.004234185,0.0002433711,0.0535774,0.000160619,0.00008138512,0.00001198637,0.00008760495,0.001316682,0.9391633,0.0004316868,0.0005179433,0.0001738143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858716,0.006388355,0.0002443351,0.006201064,0.00003608386,0.000560583,0.00002769592,0.00001497423,0.0006553064],"genre_scores_gemma":[0.9962676,0.002270774,0.0001750387,0.001094319,0.0000132136,0.00003572761,0.000001879072,0.00001467332,0.0001268004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04632517,"threshold_uncertainty_score":0.5814254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143972162","doi":"10.1158/1535-7163.mct-06-0663","title":"Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":117,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Lethbridge","funders":"","keywords":"Epigenetics; Biology; DNA methylation; Cancer epigenetics; Cancer research; Estrogen receptor; MCF-7; Cisplatin; Histone H3; Cancer cell; Histone; Vorinostat; Cancer; Histone methyltransferase; Gene expression; Genetics; Breast cancer; Histone deacetylase; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02626829853942031,"gpt":0.3103611688220568,"spread":0.2840928702826365,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004938078,0.0003301214,0.0003420685,0.0001522867,0.0001193271,0.00002910036,0.0003490934,0.0002940557,0.00001658056],"category_scores_gemma":[0.00001736256,0.0003260731,0.0001347575,0.0002619534,0.0002641191,0.000005384793,0.0001973376,0.0002331239,0.000002005676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006627598,"about_ca_system_score_gemma":0.0001316357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002481167,"about_ca_topic_score_gemma":0.00006579881,"domain_scores_codex":[0.9977406,0.0001000069,0.000496917,0.000592648,0.0004170569,0.000652778],"domain_scores_gemma":[0.9986932,0.00002805178,0.0001919336,0.0005941236,0.0002963327,0.0001964119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002059545,0.0001375008,0.01390297,0.00009241038,0.0002406499,0.00001386929,0.0001003041,0.00006934392,0.9822991,0.00003767271,0.000006982403,0.002893267],"study_design_scores_gemma":[0.001016192,0.000290989,0.0265795,0.00003678284,0.0000745645,0.00001598836,0.0000883475,0.00008745134,0.9706555,0.00004117772,0.0007633797,0.0003501073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787152,0.01339072,0.006860659,0.00007286877,0.000107026,0.0005139015,0.0001899563,0.00001730371,0.0001323429],"genre_scores_gemma":[0.9960532,0.0004360797,0.002812873,0.000229462,0.00009065322,0.00002221677,0.00007653392,0.00009313726,0.0001859071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01733791,"threshold_uncertainty_score":0.9999191,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125755807","doi":"10.1158/1535-7163.mct-14-0399","title":"ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice","year":2014,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal; Angiochem (Canada)","funders":"","keywords":"Transcytosis; Monoclonal antibody; Cancer research; Conjugate; LRP1; In vivo; Blood–brain barrier; In vitro; Biology; Antibody; Receptor; Pharmacology; Immunology; Central nervous system; Biochemistry; Endocrinology; Endocytosis","retraction":null,"screen_n_in":null,"score":{"opus":0.0195238399491707,"gpt":0.3064393769036586,"spread":0.2869155369544879,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002956323,0.0003524137,0.0005302198,0.0001707243,0.0001054517,0.000044032,0.0002446329,0.000165937,0.0001637158],"category_scores_gemma":[0.0000254068,0.0003088678,0.0002061719,0.0003790412,0.0002435571,0.00004410235,0.00007403336,0.000601556,0.00005512991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001784165,"about_ca_system_score_gemma":0.0002379819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008392816,"about_ca_topic_score_gemma":0.0002611289,"domain_scores_codex":[0.9976233,0.0001319319,0.0004199152,0.0005261223,0.0006183307,0.0006804296],"domain_scores_gemma":[0.9990397,0.0001316189,0.00009329866,0.0003124399,0.0001899633,0.0002329694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002076682,0.0007545647,0.002933445,0.0002240585,0.0005497952,0.0008263565,0.001917956,0.0003091145,0.9353986,0.0009743982,0.0002371509,0.05379784],"study_design_scores_gemma":[0.02936326,0.005284443,0.1829967,0.002163406,0.0006514488,0.0008614929,0.0005434167,0.07279973,0.5116425,0.0008645323,0.1897916,0.003037471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808091,0.001307539,0.002338691,0.01201975,0.0001405444,0.0006641937,0.0001274576,0.00004760682,0.002545159],"genre_scores_gemma":[0.9615114,0.0004364778,0.001044106,0.03595775,0.0002974803,0.0000527742,0.00006172391,0.00007466952,0.00056358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4237561,"threshold_uncertainty_score":0.9999363,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137268781","doi":"10.1158/1535-7163.mct-09-0960","title":"Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"GlaxoSmithKline (Canada); Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canada Research Chairs; GlaxoSmithKline","keywords":"Topotecan; Medicine; Pazopanib; Ovarian cancer; Pharmacology; Paclitaxel; Irinotecan; Chemotherapy; Cyclophosphamide; Ovarian carcinoma; Cancer; Oncology; Internal medicine; Sunitinib; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03021178287455396,"gpt":0.3444115221306979,"spread":0.314199739256144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001847521,0.0003074832,0.0005926796,0.00005443079,0.00009901575,0.00002039596,0.0002223767,0.00009263603,0.0001475323],"category_scores_gemma":[0.00000447057,0.0001444033,0.0006789199,0.0002161137,0.0002770405,0.00002450362,0.0000199836,0.000150047,8.78189e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003422266,"about_ca_system_score_gemma":0.0008044917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003554794,"about_ca_topic_score_gemma":0.002282975,"domain_scores_codex":[0.9986321,0.00006468112,0.0003750177,0.000328057,0.0002608541,0.0003393068],"domain_scores_gemma":[0.9983798,0.0002086804,0.0002862392,0.0008256201,0.0001959209,0.000103687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02075608,0.01005561,0.2057691,0.0002756833,0.05035168,0.0000571768,0.004490484,0.006080492,0.1306809,0.001673764,0.0006726686,0.5691364],"study_design_scores_gemma":[0.03668548,0.0157776,0.5422763,0.0002585466,0.01619941,0.00002424104,0.0003151312,0.004667925,0.364939,0.0002334338,0.01793488,0.0006880006],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794526,0.008053376,0.0005244734,0.009130679,0.0003209861,0.002222906,0.0002467112,0.00001714293,0.00003110554],"genre_scores_gemma":[0.9956879,0.002273137,0.000500494,0.000483734,0.0001418971,0.0007339494,0.00002006087,0.0000626979,0.0000961152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5684484,"threshold_uncertainty_score":0.5888597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135227533","doi":"10.1158/1535-7163.mct-08-0385","title":"Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"DNA damage; Fludarabine; Chemistry; SOD2; Molecular biology; Reactive oxygen species; Cancer research; Superoxide dismutase; Biology; Biochemistry; DNA; Oxidative stress; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02381161412216235,"gpt":0.3175093627377311,"spread":0.2936977486155687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001463625,0.00027452,0.0003269263,0.0002128167,0.0001145181,0.00001323251,0.0002210459,0.0001891962,0.0000259342],"category_scores_gemma":[0.0000393338,0.0002971356,0.0001154531,0.0003013443,0.0003201053,0.00001615048,0.0001517629,0.0003386315,0.000004408895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002391173,"about_ca_system_score_gemma":0.0003271917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003592871,"about_ca_topic_score_gemma":0.0005247163,"domain_scores_codex":[0.9982767,0.0001544125,0.0003823785,0.0004971203,0.0003085454,0.0003808123],"domain_scores_gemma":[0.9990207,0.00002358425,0.0001506098,0.0005005888,0.0001917263,0.0001128235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002370642,0.0001674566,0.0007117122,0.00002304272,0.0001143455,0.00004531147,0.000646362,0.00004382541,0.9965658,0.00003170808,0.0002055419,0.001207864],"study_design_scores_gemma":[0.001058964,0.000222014,0.00601725,0.00005117775,0.00003016672,0.00004887012,0.0002467109,0.0001453394,0.9751094,0.00002441341,0.01676112,0.0002845581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938611,0.004269654,0.00008164706,0.0002081905,0.0001174909,0.0003320489,0.00006219236,0.00001608125,0.001051545],"genre_scores_gemma":[0.9976445,0.0009631556,0.0001895737,0.0002137432,0.0001271046,0.00006442746,0.00007202655,0.00006340861,0.000662095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02145635,"threshold_uncertainty_score":0.9999481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158594431","doi":"10.1158/1535-7163.mct-08-0959","title":"Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"RAD51; Imatinib; Cancer research; Clonogenic assay; Gemcitabine; Imatinib mesylate; Mitomycin C; Chemistry; DNA repair; Biology; Molecular biology; Cell; Cancer; Medicine; Internal medicine; DNA; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02634312494014245,"gpt":0.3143477273620954,"spread":0.2880046024219529,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004988251,0.0002642319,0.0004347579,0.000154866,0.0000907353,0.00002993292,0.00005443649,0.0001304473,0.000009280227],"category_scores_gemma":[0.00003698614,0.000283252,0.0000756047,0.000371945,0.00009800715,0.000102705,0.00001938507,0.0003627632,0.000001962679],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004537735,"about_ca_system_score_gemma":0.00016413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008046566,"about_ca_topic_score_gemma":0.000008502494,"domain_scores_codex":[0.9981896,0.0001999888,0.0004351755,0.0004900513,0.0002877216,0.0003974758],"domain_scores_gemma":[0.9991547,0.00007000365,0.0002315148,0.000291729,0.0001563588,0.0000956267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006085723,0.0001994467,0.0001890251,0.00004053777,0.00002942653,0.0002017482,0.0006609938,0.0005314618,0.9745365,0.00002689745,0.00001557107,0.02295976],"study_design_scores_gemma":[0.005775109,0.0002801284,0.005492164,0.000215696,0.00007835509,0.0001032674,0.00009234074,0.01236012,0.9743083,0.000766395,0.0001953823,0.0003327703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875361,0.00190007,0.006662755,0.002068738,0.0001649902,0.0005641723,0.00002435314,0.00008071324,0.0009981029],"genre_scores_gemma":[0.9895772,0.0004339709,0.004712672,0.005081138,0.00008427288,0.00001453192,0.00002449763,0.00003703665,0.00003462859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02262699,"threshold_uncertainty_score":0.999962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158343538","doi":"10.1158/1535-7163.mct-13-0749","title":"Glioblastoma Cells Containing Mutations in the Cohesin Component <i>STAG2</i> Are Sensitive to PARP Inhibition","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Centre for Drug Research and Development","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Institute for Advanced Research","keywords":"Poly ADP ribose polymerase; Mutant; Biology; Cancer research; Molecular biology; Mutation; DNA repair; DNA damage; PARP inhibitor; Cancer cell; DNA; Cancer; Gene; Genetics; Polymerase","retraction":null,"screen_n_in":null,"score":{"opus":0.02657607525256915,"gpt":0.3001990841337632,"spread":0.2736230088811941,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002293641,0.000271247,0.0003425718,0.0001848022,0.0001230853,0.00007703299,0.0001134462,0.0001134364,0.0001196415],"category_scores_gemma":[0.000008852931,0.0002264531,0.0001205456,0.000591951,0.0001228872,0.00009188717,0.00002782384,0.0003546992,0.0001221179],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004148885,"about_ca_system_score_gemma":0.0001335695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003252314,"about_ca_topic_score_gemma":0.0001524639,"domain_scores_codex":[0.9980334,0.0002515349,0.0004011693,0.0003706316,0.0005170035,0.0004262409],"domain_scores_gemma":[0.9988772,0.0001234591,0.00015917,0.0004123466,0.0002954513,0.0001323993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004279079,0.0002575018,0.001314449,0.00004193694,0.0001643734,0.0002611612,0.005780446,0.001865387,0.9838523,0.0002942088,0.001059393,0.004680936],"study_design_scores_gemma":[0.003899799,0.0007016147,0.01304887,0.0006080049,0.0001777681,0.00009113106,0.004601974,0.001164278,0.9602732,0.0005645787,0.01437767,0.0004911015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9724903,0.0004757717,0.005955088,0.01821776,0.0002066187,0.001807548,0.00005761209,0.00007919456,0.0007101484],"genre_scores_gemma":[0.9438593,0.00009092923,0.0004819287,0.05461127,0.0001170457,0.0007072331,0.00002705986,0.0000543386,0.00005092676],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03639351,"threshold_uncertainty_score":0.9234488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1924355940","doi":"10.1158/1535-7163.149.3.2","title":"Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy <i>in vitro</i>","year":2004,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Government of Ontario","keywords":"Cancer research; Cancer cell; Biology; Cisplatin; Immunology; Chemistry; Cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01109433195069512,"gpt":0.2595333295986446,"spread":0.2484389976479494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022257,0.0004050276,0.0003487736,0.00007994162,0.0001015663,0.00005751713,0.0003313712,0.0001716616,0.00002950735],"category_scores_gemma":[0.00001547417,0.000421488,0.0001582491,0.000312156,0.00009744712,0.000008169935,0.0001060052,0.0001921904,0.00002393442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001323937,"about_ca_system_score_gemma":0.0002362911,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001132794,"about_ca_topic_score_gemma":0.00002945808,"domain_scores_codex":[0.9979337,0.00007077168,0.0003882528,0.0006656384,0.0003060244,0.0006356405],"domain_scores_gemma":[0.999219,0.00000895263,0.0001174797,0.000377982,0.0001512123,0.0001253599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003994177,0.00008041072,0.0008093792,0.00002692769,0.0001744166,0.00008247249,0.0004749504,0.003228415,0.9922821,0.00002119109,0.0001130643,0.002307286],"study_design_scores_gemma":[0.001843067,0.0001100653,0.0003623931,0.00006544067,0.00003551156,0.000008867154,0.0001985758,0.00005904613,0.9737061,0.0001368095,0.02289426,0.0005799104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822889,0.006762278,0.008711991,0.001059921,0.0003465121,0.0004656955,0.00001937619,0.00004492302,0.0003004363],"genre_scores_gemma":[0.9775828,0.0006693801,0.01159257,0.009458242,0.0002346375,0.00008696568,0.00006106948,0.0001152747,0.0001990652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0227812,"threshold_uncertainty_score":0.9998237,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053354626","doi":"10.1158/1535-7163.mct-08-0885","title":"WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of California, Irvine","keywords":"Wnt signaling pathway; Cancer research; Biology; Ectopic expression; Gene silencing; Cell biology; Signal transduction; Cell culture; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01596058149435428,"gpt":0.2749779907451785,"spread":0.2590174092508242,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001122056,0.0002288517,0.0002126636,0.00008110355,0.0001100623,0.00003437094,0.00007806494,0.000187635,0.0000062643],"category_scores_gemma":[0.000007756783,0.0002252575,0.00005597171,0.0001143877,0.0000860734,0.000009640203,0.00008488076,0.00009616943,4.489793e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002784608,"about_ca_system_score_gemma":0.00006458234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005240058,"about_ca_topic_score_gemma":0.00003530061,"domain_scores_codex":[0.9988165,0.00007670397,0.0002645566,0.0004282045,0.0001763253,0.0002377095],"domain_scores_gemma":[0.9993722,0.0000111943,0.0001405754,0.0002242817,0.0001392767,0.0001124904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006565877,0.00006772848,0.001103555,0.00004485358,0.00004756024,0.000006271577,0.0003846856,0.0001598569,0.9936131,0.00008108368,0.00003326067,0.004392382],"study_design_scores_gemma":[0.000519867,0.0007295648,0.003410835,0.0001656428,0.00004987942,0.00000150376,0.00005129932,0.0000159983,0.9929997,0.001117554,0.0006640005,0.0002742091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847257,0.01359365,0.0007647309,0.0003722178,0.0001011468,0.0003035527,0.00002684604,0.00001049435,0.0001016819],"genre_scores_gemma":[0.9952613,0.003246119,0.0004544213,0.0007034739,0.0001693759,0.00003505382,0.00003467114,0.00003307326,0.00006257398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01053556,"threshold_uncertainty_score":0.9185733,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150852167","doi":"10.1158/1535-7163.mct-08-0444","title":"Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Fibroblast growth factor receptor; Cancer research; Fibroblast growth factor receptor 1; Biology; Epidermal growth factor receptor; Fibroblast growth factor; Receptor; Cell growth; Growth factor receptor; Epidermal growth factor; Cancer cell; Lung cancer; Cancer; Signal transduction; Cell biology; Internal medicine; Medicine; Biochemistry; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01746676278443335,"gpt":0.2626455739875888,"spread":0.2451788112031554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000155663,0.0005427664,0.0004659854,0.0001402633,0.0002962919,0.00005599232,0.0004763284,0.000312198,0.0001131651],"category_scores_gemma":[0.00002551314,0.0004071443,0.0001637562,0.0005231779,0.0003319904,0.00002252185,0.0002048485,0.0003459716,0.00001191618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001326282,"about_ca_system_score_gemma":0.0005185195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004001388,"about_ca_topic_score_gemma":0.0001184958,"domain_scores_codex":[0.9971028,0.0002856184,0.0005259471,0.0008045163,0.0004854536,0.0007956516],"domain_scores_gemma":[0.9978602,0.00009688084,0.0003154009,0.0006451622,0.0007905203,0.000291855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003508207,0.0001149723,0.005651641,0.0001743966,0.0004388838,0.000004330782,0.0006048763,0.0002760258,0.991443,0.00002813613,0.0005081414,0.0004047234],"study_design_scores_gemma":[0.001251434,0.0006591232,0.01250877,0.000179114,0.00008168246,0.00000687186,0.00005990789,0.0001695182,0.982198,0.00001248175,0.002327136,0.0005459295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9725599,0.004185057,0.01779334,0.002025441,0.0001081857,0.001544601,0.001703183,0.00003574069,0.00004457098],"genre_scores_gemma":[0.9935809,0.003188991,0.000579179,0.00156849,0.0001567895,0.0004498981,0.0002040983,0.0001438182,0.0001278514],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.021021,"threshold_uncertainty_score":0.9998381,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126724373","doi":"10.1158/1535-7163.mct-05-0064","title":"A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells","year":2005,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Antisense therapy; Bcl-xL; Apoptosis; XIAP; Oligonucleotide; Biology; Cancer research; Inhibitor of apoptosis; LNCaP; Prostate cancer; Molecular biology; Caspase; Programmed cell death; Cancer; Biochemistry; Gene; Genetics; Locked nucleic acid","retraction":null,"screen_n_in":null,"score":{"opus":0.01596369121931365,"gpt":0.2679292000416075,"spread":0.2519655088222938,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002282677,0.0003468792,0.0003056511,0.00009613827,0.0001586556,0.00007874482,0.0001153403,0.000236447,0.00001034349],"category_scores_gemma":[0.000003060686,0.0003482998,0.0001022581,0.0001771376,0.0001116367,0.00002144223,0.0001184494,0.0001954064,0.000001113151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008318597,"about_ca_system_score_gemma":0.00009920154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005899026,"about_ca_topic_score_gemma":0.0007108377,"domain_scores_codex":[0.9981695,0.00007717325,0.0003622101,0.0006393548,0.0002727061,0.0004790235],"domain_scores_gemma":[0.9993622,0.000007900234,0.0001868915,0.0002466855,0.00009318138,0.0001031368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006216748,0.0001085171,0.0003188962,0.00004735529,0.0001315538,0.000008202387,0.0003698918,0.003901477,0.976842,0.00002825561,0.000008477538,0.01817322],"study_design_scores_gemma":[0.001307094,0.00009073271,0.001632749,0.00009828544,0.0000847129,0.00001312883,0.0001633924,0.001664055,0.9932562,0.00002474199,0.00120436,0.0004606104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938977,0.004270598,0.0007555028,0.0002946724,0.0001674405,0.0004407584,0.00004362852,0.0000232425,0.0001064066],"genre_scores_gemma":[0.993284,0.004139479,0.00108264,0.00102662,0.0001674135,0.00004678473,0.00003894861,0.00006402122,0.0001500647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01771261,"threshold_uncertainty_score":0.9998969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129944198","doi":"10.1158/1535-7163.mct-14-1078","title":"AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma","year":2015,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Cancer research; Antibody-drug conjugate; Epidermal growth factor receptor; Antibody; Conjugate; Chemistry; Monoclonal antibody; Molecular biology; Medicine; Receptor; Biology; Immunology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04084305897425566,"gpt":0.3333669018782425,"spread":0.2925238429039868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002568735,0.0005288502,0.0007196782,0.0002252193,0.0002004985,0.0001685119,0.0002576331,0.0001752254,0.00002701887],"category_scores_gemma":[0.00001565444,0.0004510945,0.0002326427,0.0004470174,0.0001915029,0.0002867019,0.0001105481,0.0003638708,0.00003388565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003244163,"about_ca_system_score_gemma":0.0004380126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004046272,"about_ca_topic_score_gemma":0.00006873353,"domain_scores_codex":[0.9972202,0.0001979129,0.0003809482,0.000721744,0.0007990762,0.0006801857],"domain_scores_gemma":[0.9979835,0.00002890257,0.0002514275,0.0008328203,0.0003625659,0.0005408023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004042981,0.0017423,0.01885375,0.00007126494,0.0007152296,0.001473526,0.0007354231,0.0004333607,0.9445757,0.0000697734,0.0001278907,0.03079746],"study_design_scores_gemma":[0.00527082,0.0007682018,0.02558823,0.0003938384,0.0006759553,0.0001023967,0.0003430896,0.00153837,0.9565059,0.0000807444,0.008111664,0.0006207995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901453,0.005319033,0.0002801139,0.001929955,0.0005442391,0.0006914506,0.00005656218,0.0001788895,0.0008544155],"genre_scores_gemma":[0.9949281,0.0008099709,0.0005058377,0.003216288,0.0002317063,0.00007832728,0.00006312216,0.0001180495,0.00004862607],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03017666,"threshold_uncertainty_score":0.9997941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126163147","doi":"10.1158/1535-7163.mct-08-1186","title":"Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"University of Southern California","keywords":"Breast cancer; Cancer research; Cancer; Doxorubicin; Carcinogen; Paclitaxel; Oxidative stress; Cancer cell; Biology; Cytotoxicity; Molecular biology; Chemistry; Chemotherapy; Endocrinology; Biochemistry; In vitro; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.009806876768941873,"gpt":0.2616770354476037,"spread":0.2518701586786618,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009280987,0.0003135685,0.0003023325,0.00007255442,0.00006695232,0.00004488293,0.0001148556,0.0001486884,0.000007478924],"category_scores_gemma":[0.00001306266,0.0002893886,0.00003915829,0.0002068923,0.00005815686,0.00000718314,0.00009172912,0.0001195742,7.210185e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000885081,"about_ca_system_score_gemma":0.00007559162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002917194,"about_ca_topic_score_gemma":0.0006157033,"domain_scores_codex":[0.9985178,0.00007734913,0.0001746637,0.0006523384,0.0001792874,0.0003985396],"domain_scores_gemma":[0.9992338,0.00001367301,0.00006982576,0.0002928482,0.0001575186,0.000232339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004440468,0.00007707467,0.04451654,0.0000109768,0.0001258772,0.000007926962,0.0007809042,0.0002550179,0.9449507,0.000005391625,0.0001589534,0.00866658],"study_design_scores_gemma":[0.0008491686,0.0002665167,0.1613255,0.0002277121,0.00003051344,0.000004015758,0.0001013714,0.00003692366,0.8359039,0.00004296889,0.0008283556,0.0003829885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914817,0.001425725,0.0009139478,0.005007992,0.00002447035,0.0005370867,0.0005670701,0.0000115236,0.00003044362],"genre_scores_gemma":[0.9791554,0.0006602462,0.0006507675,0.01930505,0.00006719915,0.0000553704,0.00003518418,0.00003575472,0.00003505962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.116809,"threshold_uncertainty_score":0.9999558,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2120070286","doi":"10.1158/1535-7163.mct-13-0598","title":"Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Università di Catania","keywords":"Pharmacology; In vitro; Signal transduction; Cancer; In vivo; Receptor; Monoclonal antibody; Cancer cell; Growth inhibition; Antibody; Cancer research; Biology; Medicine; Immunology; Cell biology; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02132143641633652,"gpt":0.3013254112828246,"spread":0.280003974866488,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008418628,0.0001981509,0.0003150913,0.0001276496,0.0001106701,0.00003176092,0.00004862256,0.00007908943,0.00001249732],"category_scores_gemma":[0.000008502447,0.0001666926,0.00004676106,0.0001547835,0.0001074064,0.0001179,0.00002090395,0.0001236018,5.035333e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003425726,"about_ca_system_score_gemma":0.00008667642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001343864,"about_ca_topic_score_gemma":0.00001650889,"domain_scores_codex":[0.9990875,0.00003136922,0.0002100807,0.0002572995,0.0001993687,0.0002144471],"domain_scores_gemma":[0.9993554,0.00006385943,0.0001392543,0.0001309698,0.0002233415,0.0000872254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002025724,0.0001314427,0.005265985,0.000325148,0.0002313993,0.000004253001,0.0002616249,0.0000106809,0.9899353,0.001148187,0.000008609345,0.002474782],"study_design_scores_gemma":[0.00731498,0.00175835,0.06617742,0.000236794,0.0009148997,0.00004130668,0.0001145483,0.01777432,0.903704,0.001354299,0.0002376803,0.0003714446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809019,0.0009860827,0.01633373,0.0005760331,0.00005276085,0.001044044,0.00002247706,0.00002857171,0.00005441737],"genre_scores_gemma":[0.9985473,0.0003064626,0.0004795782,0.0004138849,0.00002519068,0.00009770099,0.0000418126,0.00003934464,0.0000487757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08623136,"threshold_uncertainty_score":0.6797528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023431277","doi":"10.1158/1535-7163.mct-15-0067","title":"AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML","year":2015,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Antibody-drug conjugate; Pharmacology; Medicine; Drug; Conjugate; Antibody; Immunology; Monoclonal antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.05551429481243274,"gpt":0.3826702077750343,"spread":0.3271559129626015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008142739,0.0004641226,0.0007404587,0.0003058902,0.0001160791,0.0001603316,0.0003551649,0.0002189713,0.0000439899],"category_scores_gemma":[0.00004410677,0.0004453868,0.0002036611,0.0004214701,0.0002226964,0.0001571003,0.00008551475,0.0003652805,0.000008812786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003170771,"about_ca_system_score_gemma":0.00178237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001538756,"about_ca_topic_score_gemma":0.0003042209,"domain_scores_codex":[0.9968098,0.0001880147,0.0005676459,0.0008125601,0.0006409776,0.0009810089],"domain_scores_gemma":[0.9980686,0.0001012107,0.0001848221,0.0006410477,0.0004288217,0.0005754638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004629747,0.0007469954,0.006248447,0.0007706166,0.0005782331,0.000174771,0.006226867,0.0006570152,0.9119869,0.0007263725,0.00106217,0.0661919],"study_design_scores_gemma":[0.03794439,0.00737045,0.004762929,0.0006324247,0.001418384,0.0001456638,0.004512423,0.03868015,0.6136426,0.02299282,0.2658356,0.002062086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9203674,0.04305494,0.02446278,0.006961592,0.0003878536,0.004063972,0.0002071122,0.0001156956,0.0003786739],"genre_scores_gemma":[0.9824634,0.001901381,0.00594446,0.006702167,0.0003176448,0.0006288826,0.0001320088,0.0002291182,0.001680999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2983442,"threshold_uncertainty_score":0.9997998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1864382350","doi":"10.1158/1535-7163.641.3.5","title":"Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer","year":2004,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Pancreatic cancer; Identification (biology); Cancer; Polo-like kinase; Kinase; Biology; Cancer research; Computational biology; Genetics; Cell cycle","retraction":null,"screen_n_in":null,"score":{"opus":0.01038560475883959,"gpt":0.2819086709854192,"spread":0.2715230662265796,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001384295,0.0002510234,0.0002573654,0.0001059983,0.00006885179,0.00002570819,0.0003102642,0.0002192342,0.00003739747],"category_scores_gemma":[0.000004261546,0.0002614543,0.0001574415,0.0002142327,0.0001290793,0.000007262024,0.00006511845,0.0001453609,0.000004471316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001052669,"about_ca_system_score_gemma":0.0002636818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009319137,"about_ca_topic_score_gemma":0.0003894067,"domain_scores_codex":[0.9984851,0.00008167863,0.0004443886,0.0004273588,0.0002161518,0.0003452566],"domain_scores_gemma":[0.9991063,0.000002997213,0.000210876,0.0004994039,0.000120138,0.00006032317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008779143,0.0001858659,0.002246373,0.00004431675,0.0002205937,0.00001209727,0.0001768688,0.00439094,0.9904155,0.0005198811,0.000007272977,0.001692497],"study_design_scores_gemma":[0.001402584,0.0002106421,0.002746612,0.0000524837,0.0001556256,0.000007591178,0.00009463171,0.0001620221,0.9912426,0.002021105,0.001582391,0.0003216774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9748293,0.01569686,0.008386225,0.0003434701,0.000218029,0.0003866733,0.00005247791,0.00001409484,0.00007288413],"genre_scores_gemma":[0.995283,0.002404442,0.0001580839,0.00157561,0.00008163769,0.0001473456,0.00008777984,0.00005989161,0.0002021942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02045373,"threshold_uncertainty_score":0.9999838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}